TY - JOUR
T1 - Low nucleotide diversity of the Plasmodium falciparum AP2-EXP2 gene among clinical samples from Ghana
AU - Quansah, Elvis
AU - Zhao, Ji
AU - Eduful, Kenneth Kofi
AU - Amoako, Enock Kofi
AU - Amenga-Etego, Lucas
AU - Halm-Lai, Faustina
AU - Luo, Qingli
AU - Shen, Jilong
AU - Zhang, Chao
AU - Yu, Li
N1 - Publisher Copyright:
© 2024. The Author(s).
PY - 2024/11/5
Y1 - 2024/11/5
N2 - BACKGROUND: PfAP2-EXP2 is located within chromosome 6 of Plasmodium falciparum recently identified to be undergoing an extensive selective sweep in West African isolates. The gene encoding this transcription factor, PfAP2-EXP2, is essential and thus likely subject to purifying selection that limits variants in the parasite population despite its genomic location. METHODS: 72 Plasmodium falciparum field samples and 801 clinical sequences from the Pf6 MalariaGEN dataset of Ghanaian origin, were integrated and analysed. RESULTS: A total of 14 single nucleotide variants of which 5 were missense variants, were identified after quality checks and filtering. Except for one, all identified variants were rare among the clinical samples obtained in this study (Minor allelic frequency < 0.01). Further results revealed a considerably low dN/dS value (0.208) suggesting the presence of purifying selection. Further, all the mutant amino acids were wildtype residues in AP2-EXP2 orthologous proteins-tentatively suggesting a genus-level conservation of amino acid residues. Computational analysis and predictions corroborated these findings. CONCLUSIONS: Despite the recent extensive selective sweep within chromosome 6 of West African isolates, PfAP2-EXP2 of Ghanaian origin exhibits low nucleotide diversity and very low dN/dS consistent with purifying selection acting to maintain the function of an essential gene. The conservation of AP2-EXP2 is an important factor that makes it a potential drug target.
AB - BACKGROUND: PfAP2-EXP2 is located within chromosome 6 of Plasmodium falciparum recently identified to be undergoing an extensive selective sweep in West African isolates. The gene encoding this transcription factor, PfAP2-EXP2, is essential and thus likely subject to purifying selection that limits variants in the parasite population despite its genomic location. METHODS: 72 Plasmodium falciparum field samples and 801 clinical sequences from the Pf6 MalariaGEN dataset of Ghanaian origin, were integrated and analysed. RESULTS: A total of 14 single nucleotide variants of which 5 were missense variants, were identified after quality checks and filtering. Except for one, all identified variants were rare among the clinical samples obtained in this study (Minor allelic frequency < 0.01). Further results revealed a considerably low dN/dS value (0.208) suggesting the presence of purifying selection. Further, all the mutant amino acids were wildtype residues in AP2-EXP2 orthologous proteins-tentatively suggesting a genus-level conservation of amino acid residues. Computational analysis and predictions corroborated these findings. CONCLUSIONS: Despite the recent extensive selective sweep within chromosome 6 of West African isolates, PfAP2-EXP2 of Ghanaian origin exhibits low nucleotide diversity and very low dN/dS consistent with purifying selection acting to maintain the function of an essential gene. The conservation of AP2-EXP2 is an important factor that makes it a potential drug target.
KW - Plasmodium falciparum
KW - Malaria
KW - Nucleotide variation
KW - Transcriptional factor AP2-EXP2
UR - http://www.scopus.com/inward/record.url?scp=85208602839&partnerID=8YFLogxK
U2 - 10.1186/s13071-024-06545-6
DO - 10.1186/s13071-024-06545-6
M3 - Article
C2 - 39501336
AN - SCOPUS:85208602839
SN - 1756-3305
VL - 17
SP - 453
JO - Parasites and Vectors
JF - Parasites and Vectors
IS - 1
ER -